A Study for Patients With Complicated Skin and Skin Structure Infections

NCT00514527 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Skin Infections
Wounds and Injuries
Abscess
Cellulitis
Streptococcal Infections

Interventions

DRUG: oritavancin

Sponsor

Targanta Therapeutics Corporation